rVSV-ZEBOV vaccine first real-world data support prophylactic use for future Ebola outbreaks:… EP News Bureau Aug 28, 2024 Real-world data show rVSV-ZEBOV vaccine is 84 per cent effective against Ebola, supporting its use in future outbreaks
Merck and Gavi sign purchase commitment for Ebola vaccine Usha Sharma Jan 21, 2016 Agreement will help prepare for future outbreaks and push vaccine towards regulatory approval
